VISILIZUMAB
UNII H18SKU3289

Substance Identification & Data

This profile provides standardized clinical and technical data for Visilizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H18SKU3289.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 219716-33-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H18SKU3289

CAS Registry Number

219716-33-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VISILIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2229

National Cancer Institute reference terminology for clinical and research data.

INN ID

8054

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KK-166

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Visilizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VISILIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2 (HUMAN-MOUSE MONOCLONAL HUM291 .GAMMA.2-CHAIN ANTI-HUMAN ANTIGEN CD3), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUM291 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G2 (HUMAN-MOUSE MONOCLONAL HUM291 .GAMMA.2-CHAIN ANTI-HUMAN ANTIGEN CD3), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HUM291 .KAPPA.-CHAIN, DIMER

MAB HUMANIZED (IGG2) ANTI P09693 (CD3G_HUMAN) (HUM291)

MAB HUMANIZED TO CD3+ T CELLS

VISILIZUMAB [INN]

VISILIZUMAB [USAN]

VISILIZUMAB [WHO-DD]